Honghui Zhou

6.7k total citations
176 papers, 5.2k citations indexed

About

Honghui Zhou is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Honghui Zhou has authored 176 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 52 papers in Radiology, Nuclear Medicine and Imaging and 36 papers in Rheumatology. Recurrent topics in Honghui Zhou's work include Monoclonal and Polyclonal Antibodies Research (52 papers), Rheumatoid Arthritis Research and Therapies (27 papers) and Biosimilars and Bioanalytical Methods (27 papers). Honghui Zhou is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (52 papers), Rheumatoid Arthritis Research and Therapies (27 papers) and Biosimilars and Bioanalytical Methods (27 papers). Honghui Zhou collaborates with scholars based in United States, Belgium and China. Honghui Zhou's co-authors include Hugh M. Davis, Zhenhua Xu, Chuanpu Hu, Omoniyi J. Adedokun, Adedigbo A. Fasanmade, Mary Ann Mascelli, Jewel Johanns, Joyce Ford, Bernd Meibohm and Marion Blank and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Biotechnology.

In The Last Decade

Honghui Zhou

174 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Honghui Zhou United States	40	2.0k	1.2k	1.1k	992	859	176	5.2k
Hugh M. Davis United States	39	2.0k 1.0×	1.4k 1.1×	1.2k 1.1×	1.2k 1.2×	604 0.7×	93	5.0k
Kevin Horgan United States	34	2.3k 1.2×	812 0.7×	820 0.7×	1.0k 1.0×	302 0.4×	63	9.1k
Naoyuki Kamatani Japan	51	1.3k 0.7×	1.5k 1.3×	323 0.3×	2.8k 2.9×	1.1k 1.3×	179	8.9k
Cristiano Alessandri Italy	47	1.9k 1.0×	514 0.4×	769 0.7×	1.4k 1.4×	3.1k 3.7×	305	6.8k
Poupak Fallahi Italy	59	2.1k 1.0×	1.6k 1.3×	295 0.3×	1.9k 1.9×	1.6k 1.8×	298	10.8k
J Bariéty France	45	1.6k 0.8×	453 0.4×	391 0.3×	1.6k 1.6×	958 1.1×	221	7.0k
Byron P. Croker United States	41	2.4k 1.2×	551 0.5×	438 0.4×	1.3k 1.3×	1.4k 1.7×	100	5.3k
Emile de Heer Netherlands	47	1.3k 0.7×	1.7k 1.4×	222 0.2×	2.9k 2.9×	516 0.6×	204	8.5k
Yusuke Suzuki Japan	45	2.0k 1.0×	249 0.2×	382 0.3×	1.7k 1.7×	743 0.9×	320	8.0k
Fabrizio Conti Italy	47	2.0k 1.0×	643 0.5×	762 0.7×	1.2k 1.2×	3.6k 4.2×	320	6.6k

Countries citing papers authored by Honghui Zhou

Since Specialization

Citations

This map shows the geographic impact of Honghui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honghui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honghui Zhou more than expected).

Fields of papers citing papers by Honghui Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honghui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honghui Zhou. The network helps show where Honghui Zhou may publish in the future.

Co-authorship network of co-authors of Honghui Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Honghui Zhou. A scholar is included among the top collaborators of Honghui Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honghui Zhou. Honghui Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Haddish‐Berhane, Nahor, Alberto Russu, Meena Thayu, et al.. (2023). Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non‐Small Cell Lung Cancer. Clinical Pharmacology & Therapeutics. 115(3). 468–477. 5 indexed citations

Li, Zhen, Xun Zhan, W. Świȩch, et al.. (2023). An examination of the precipitation behavior of proton irradiated dual phase 308L weldment filler materials. Journal of Nuclear Materials. 577. 154287–154287. 4 indexed citations

Peletier, L. A., et al.. (2023). The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies. CPT Pharmacometrics & Systems Pharmacology. 12(5). 639–655. 4 indexed citations

Lee, Jong Bong, Yijun Fan, Chuanpu Hu, et al.. (2022). Population Pharmacokinetic and Exposure–Response Model Simulations: Predicted Exposure and Efficacy for Maintenance Doses of Intravenous Golimumab Every 6 or 8 Weeks in Patients With Moderately to Severely Active Rheumatoid Arthritis. Clinical Therapeutics. 44(3). 457–464.e2. 1 indexed citations

Chen, Junhui, Yuan Li, Zhongwei Meng, et al.. (2022). Study on Emission Characteristics and Emission Reduction Effect for Construction Machinery under Actual Operating Conditions Using a Portable Emission Measurement System (Pems). International Journal of Environmental Research and Public Health. 19(15). 9546–9546. 9 indexed citations

Hu, Chuanpu, Honghui Zhou, & Amarnath Sharma. (2020). Facilitating Longitudinal Exposure-Response Modeling of a Composite Endpoint Using the Joint Modeling of Sparsely and Frequently Collected Subcomponents. The AAPS Journal. 22(4). 79–79. 4 indexed citations

Zhang, Manli, Honghui Zhou, Yanping Lu, et al.. (2016). Application of targeted exome capture in identifying genetic mutations in ciliopathies. Zhonghua weichan yixue zazhi. 19(6). 422–426. 1 indexed citations

Clemens, Pamela L., Xiaoyu Yan, Henk M. Lokhorst, et al.. (2016). Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment. Clinical Pharmacokinetics. 56(8). 915–924. 63 indexed citations

Xu, Zhenhua, Hugh M. Davis, & Honghui Zhou. (2015). Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety. The Journal of Clinical Pharmacology. 55(S3). S60–74. 42 indexed citations

10.

Hu, Chuanpu & Honghui Zhou. (2015). Improvement in latent variable indirect response joint modeling of a continuous and a categorical clinical endpoint in rheumatoid arthritis. Journal of Pharmacokinetics and Pharmacodynamics. 43(1). 45–54. 17 indexed citations

11.

Fetterly, Gerald J., Chris H. Takimoto, Shobha Seetharam, et al.. (2013). Utilizing pharmacokinetics/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data. The Journal of Clinical Pharmacology. 53(10). 1020–1027. 26 indexed citations

12.

Wang, Weirong, et al.. (2013). Mechanistic Pharmacokinetic/Target Engagement/Pharmacodynamic (PK/TE/PD) Modeling in Deciphering Interplay Between a Monoclonal Antibody and Its Soluble Target in Cynomolgus Monkeys. The AAPS Journal. 16(1). 129–139. 33 indexed citations

13.

Zhu, Yaowei, Chuanpu Hu, Ming Lu, et al.. (2009). Population Pharmacokinetic Modeling of Ustekinumab, a Human Monoclonal Antibody Targeting IL‐12/23p40, in Patients With Moderate to Severe Plaque Psoriasis. The Journal of Clinical Pharmacology. 49(2). 162–175. 135 indexed citations

14.

Zhang, Xiaobin, Zhijun Zhang, Weiwei Sha, et al.. (2009). Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Research. 170(2-3). 273–275. 44 indexed citations

15.

Zhang, Xiaobin, Zhijun Zhang, Chunming Xie, et al.. (2008). Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(3). 886–890. 72 indexed citations

16.

Zhou, Honghui, Haishan Jang, Roy Fleischmann, et al.. (2007). Pharmacokinetics and Safety of Golimumab, a Fully Human Anti‐TNF‐α Monoclonal Antibody, in Subjects With Rheumatoid Arthritis. The Journal of Clinical Pharmacology. 47(3). 383–396. 149 indexed citations

17.

Lee, Howard, Dong‐Seok Yim, Honghui Zhou, & Carl C. Peck. (2005). Evidence of effectiveness: How much can we extrapolate from existing studies?. The AAPS Journal. 7(2). E467–E474. 14 indexed citations

18.

Zhou, Honghui, Virginia Parks, Alain Patat, et al.. (2004). Absence of a Clinically Relevant Interaction Between Etanercept and Digoxin. The Journal of Clinical Pharmacology. 44(11). 1244–1251. 24 indexed citations

19.

Swan, Suzanne K., Honghui Zhou, Ann D. Horowitz, et al.. (2003). Tegaserod Pharmacokinetics Are Similar in Patients with Severe Renal Insufficiency and in Healthy Subjects. The Journal of Clinical Pharmacology. 43(4). 359–364. 11 indexed citations

20.

Hassell, Alan E., Peter P. Lee, Honghui Zhou, et al.. (1999). Lack of Effect of Erythromycin and Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Steady‐State Intranasal Levocabastine. The Journal of Clinical Pharmacology. 39(1). 76–85. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact